Use access key #2 to skip to page content.
$3.24 -0.37 (-10.25%)
10/15/2008 4:00 PM

Neurocrine Biosciences, Inc. (NBIX)

CAPS Rating:
***

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

View All Commentary (NBIX)

Recs

0

Avatar bennybo (58.86) Submitted: 7/14/08 1:21 AM : Outperform Start Price: $4.73 NBIX Score: -3.29

Big short interest. Any good news might shoot it up.

Report this Post Replies: 0 | Reply

Featured Broker Partners

Sponsored Links